Improvement of Patients with Long COVID 19

Authors

  • Elona Zhiva Elona Zhiva, Faculty of Medical Technical Sciences, University of Elbasan Aleksander Xhuvani, Albania. Author

DOI:

https://doi.org/10.47363/JOLRR/2024(3)12

Keywords:

COVID‐19, Pulmonary Fibrosis

Abstract

Introduction: The term “long-term Covid” is commonly used to describe signs and symptoms that persist or develop after acute Covid-19. Recovery time for these patients may vary depending on other comorbidities and the severity of the disease, severely ill patients are more likely to have a longer course than those with mild or moderate disease.
Objective: The purpose of the study is the management of patients with post-Covid-19 complications, with the aim of early treatment of these complications, so that patients can return to their previous lives.
Materials and Methods: This is an observational study. Data were collected from the medical records of 60 patients hospitalized in “Shefqet Ndroqi” hospital, Tirana, in the internal pathology ward, where post-Covid 19 patients are treated, were reviewed. Their demographic, clinical, physiological, laboratory and imaging data were collected. These patients were followed in the period, March 2022-June 2022.
Results: From the 60 patients who were clinically followed for 10 weeks, it was found that at the end of the 10th week, 25.6% of the patients had a significant improvement, 64% of the patients had a slight improvement, and 10.4% of these patients had no improvement. no improvement, compared to their previous condition.
Conclusion: The elderly and those with severe symptoms during the acute phase are at greater risk of moderate and severe sequelae, which require multidisciplinary management, according to the patient’s condition.

Author Biography

  • Elona Zhiva, Elona Zhiva, Faculty of Medical Technical Sciences, University of Elbasan Aleksander Xhuvani, Albania.

    Elona Zhiva, Faculty of Medical Technical Sciences, University of Elbasan Aleksander Xhuvani, Albania.

Downloads

Published

2024-07-30